masoprocol and Leukemia, T-Cell

masoprocol has been researched along with Leukemia, T-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Goda, AE; Horinaka, M; Miki, T; Mizutani, Y; Nakata, S; Nishikawa, A; Sakai, T; Shiraishi, T; Wakada, M; Yasuda, T; Yoshida, T	1

Other Studies

1 other study(ies) available for masoprocol and Leukemia, T-Cell

Article	Year
Lipoxygenase inhibitors induce death receptor 5/TRAIL-R2 expression and sensitize malignant tumor cells to TRAIL-induced apoptosis. Cancer science, 2007, Volume: 98, Issue:9 Topics: Apoptosis; Apoptosis Regulatory Proteins; Benzoquinones; Cell Line, Tumor; Down-Regulation; Drug Synergism; Humans; Immunoglobulin Fc Fragments; Jurkat Cells; Leukemia, T-Cell; Lipoxygenase Inhibitors; Masoprocol; Mutant Chimeric Proteins; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand; Up-Regulation	2007

Article

Year

Lipoxygenase inhibitors induce death receptor 5/TRAIL-R2 expression and sensitize malignant tumor cells to TRAIL-induced apoptosis.

Cancer science, 2007, Volume: 98, Issue:9

Topics: Apoptosis; Apoptosis Regulatory Proteins; Benzoquinones; Cell Line, Tumor; Down-Regulation; Drug Synergism; Humans; Immunoglobulin Fc Fragments; Jurkat Cells; Leukemia, T-Cell; Lipoxygenase Inhibitors; Masoprocol; Mutant Chimeric Proteins; Receptors, TNF-Related Apoptosis-Inducing Ligand; TNF-Related Apoptosis-Inducing Ligand; Up-Regulation

2007